Federal Register / Vol. 58, No. 102 / Friday, May 28, 1993 / Notices 
31045 
Study section 
June-July 1993 
meetings 
Time 
Location 
Clinical Sciences-2, Mrs. Jo Pelham, Tel. 301-594- 
7254. 
July 8-9 
8:00 
Residence Inn Marriott, Bethesda, MD. 
Immunology, Virology & Pathology, Dr. Lynwood 
Jones. Tel. 301-594-7262. 
July 14-16 
8:30 
Holiday Inn, Chevy Chase MD. 
Internationa) & Cooperative Projects, Dr. G. B. War- 
ren, Tel. 301-594-7289. 
July 22-23 
8:00 
Embassy Suites Hotel, Chevy Chase Pavilion, Wash- 
ington, DC. 
Physiological Sciences, Dr. Nicholas Mazarella, Tel. 
301-594-7098. 
July 8-9 
8:00 
Holiday Inn, Crowne Plaza, Rockville, MD. 
(Catalog of Federal Domestic Assistance 
Program Nos. 93.306. 93.333, 93.337, 93.393- 
93.396, 93.837-93.844. 93.846-93.878. 
93.892, 93.893, National Institutes of Health, 
HHS) 
Dated: May 24, 1993. 
Susan K. Feldman, 
Committee Management Officer, NIH. 
[FR Doc. 93-12656 Filed 5-27-93; 8:45 am] 
BILUNG CODE 41 40-01 -M 
Recombinant DNA Advisory 
Committee; Amend Notice of Meeting 
Notice is hereby given to announce 
partial closure of the Recombinant DNA 
Advisory Committee meeting on June 7- 
8, 1993. The notice of meeting was 
published in the Federal Register on 
May 4, 1993 (58 FR 26676). 
In accordance with the provisions set 
forth in section 552b(c)(6), title 5, U.S.C. 
and section 10(d) of Public Law 92-463, 
the meeting will be closed to the public 
on June 7 from approximately 5:40 p.m. 
to approximately 6:40 p.m., for the 
report and review of the expedited 
approval of a human gene transfer 
protocol submitted by Drs. Robert E. 
Sobol and Ivor Royston, including 
consideration of information of a 
personal nature, e.g., an individual’s 
clinical records and findings, the 
disclosure of which would constitute a 
clearly unwarranted invasion of 
personal privacy. 
Dated: May 19, 1993. 
Susan K. Feldman, 
Committee Management Officer, NIH. 
|FR Doc. 93-12747 Filed 5-27-93; 8:45 am] 
BILUNG CODE 4140-01-44 
Recombinant DNA Research: 
Proposed Actions Under the 
Guidelines — Correction 
AGENCY: National Institutes of Health, 
PHS, DHHS. 
ACTION: Notice of Proposed Actions 
Under the NIH Guidelines for Research 
Involving Recombinant DNA Molecules 
(51 FR 16958). 
CORRECTION: On May 4, 1993 (58 FR 
26676), the NIH published Proposed 
Actions to be discussed during the 
upcoming meeting on June 7-8, 1993. 
The following additional item will be 
considered at that meeting: 
XXm. Report on Expedited Approval 
of Human Gene Transfer Protocol. In a 
letter dated April 30, 1993, Drs. Robert 
E. Sobol and Ivor Royston of the San 
Diego Regional Cancer Center, San 
Diego, California, requested the 
expedited review of a human gene 
transfer protocol. This request was for: 
(1) Additional treatment to a patient and 
(2) transduction of cells with a 
retrovirus vector, GlNaCvi2. 
In accordance with the Procedures for 
Expedited Review of the National 
Institutes of Health (NIH) Guidelines for 
Research Involving Recombinant DNA 
Molecules (58 FR 21741), this request 
was reviewed by both intramural and 
extramural scientists. Drs. Royston and 
Sobol submitted additional 
documentation at the request of 
reviewers. Following evaluation of the 
additional data, the reviewers 
concluded that the preclinical and 
clinical information provided by the 
investigators was sufficient to justify 
continuation of the study with the new 
vector. The Director, NIH, approved Drs. 
Royston and Sobol’s request on May 11, 
1993. 
The Procedures for Expedited Review, 
state in item number 7: "The NIH will 
report to the Recombinant DNA 
Advisory Committee (RAC) following 
expedited review and will include all of 
the materials on which the decision was 
based. The RAC will formally review 
the protocol at its next scheduled 
meeting. Patient privacy will be 
maintained." The RAC will review the 
expedited approval by the NIH Director 
at the June 7, 1993, meeting during a 
session that will be closed in order to 
protect patient privacy. 
Dated: May 24, 1993. 
Jay Moskowitz, 
Deputy Director for Science Policy and 
Technology Transfer, NIH. 
[FR Doc. 93-12748 Filed 5-27-93; 8:45 am] 
BILLING CODE 4140-01-14 
DEPARTMENT OF HOUSING AND 
URBAN DEVELOPMENT 
Office of the Assistant Secretary for 
Community Planning and 
Development 
[Docket No. N-93-1917; FR-3350-N-33] 
Federal Property Suitable as Facilities 
To Assist the Homeless 
AGENCY: Office of the Assistant 
Secretary for Community Planning and 
Development, HUD. 
ACTION: Notice. 
SUMMARY: This Notice identifies 
unutilized, underutilized, excess, and 
surplus Federal property reviewed by 
HUD for suitability for possible use to 
assist the homeless. 
ADDRESSES: For further information, 
contact James N. Forsberg, room 7262, 
Department of Housing and Urban 
Development, 451 Seventh Street SW., 
Washington, DC 20410; telephone (202) 
708-4300; TDD number for the hearing- 
and speech-impaired (202) 708-2565 
(these telephone numbers are not toll- 
free), or call the toll-free title V 
information line at 1-800-927-7588. 
SUPPLEMENTARY INFORMATION: In 
accordance with 56 FR 23789 (May 24, 
1991) and section 501 of the Stewart B. 
McKinney Homeless Assistance Act (42 
U.S.C. 11411), as amended, HUD is 
publishing this Notice to identify 
Federal buildings and other real 
property that HUD has reviewed for 
suitability for use to assist the homeless. 
The properties were reviewed using 
information provided to HUD by 
Federal landholding agencies regarding 
unutilized and underutilized buildings 
and real property controlled by such 
agencies or by GSA regarding its 
inventory of excess or surplus Federal 
property. This Notice is also published 
in order to comply with the December 
12, 1988 Court Order in National 
Coalition for the Homeless v. Veterans 
Administration, No. 88-2503-OG 
(D.D.C.). 
Properties reviewed are listed in this 
Notice according to the following 
categories: Suitable/available, suitable/ 
[538] 
Recombinant DNA Research, Volume 17 
